Woodard GA, Kratz JR, Haro G, Gubens MA, et al. Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy. Clin Lung Cancer 2021 Aug 20. pii: S1525-7304(21)00212.
PMID: 34544620